FARGION, SILVIA ROSSANA

FARGION, SILVIA ROSSANA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 443 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
{PD}-1/{PD}-L1 Immuno-Mediated Therapy in {NAFLD}: Advantages and Obstacles in the Treatment of Advanced Disease 2022 Rosa LombardiRoberto PiciottiPaola DongiovanniMarica MeroniSilvia FargionAnna Ludovica Fracanzani Article (author) -
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 2022 M. MeroniE. PaoliniM. LongoR. PiciottiS. FargionA. Ludovica FracanzaniP. Dongiovanni + Article (author) -
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown 2022 Cinque F.Cespiati A.Lombardi R.Costantino A.Maffi G.Alletto F.Colavolpe L.Francione P.Oberti G.Fatta E.Bertelli C.Sigon G.Dongiovanni P.Fargion S.Fracanzani A. L. + Article (author) -
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD 2021 Dongiovanni P.Pelusi S.Rametta R.Fracanzani A. L.Fargion S.Valenti L. + Article (author) -
Genetics, immunity and nutrition boost the switching from nash to hcc 2021 Dongiovanni P.Longo M.Fargion S.Fracanzani A. L. + Article (author) -
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 2020 Lombardi R.Villani R.Rinaldi L.Orsi E.Fargion S.Fracanzani A. L. + Article (author) -
Dysmetabolic hyperferritinemia and dysmetabolic iron overload syndrome (Dios): Two related conditions or different entities? 2020 Rametta R.Fracanzani A. L.Fargion S.Dongiovanni P. Article (author) -
Liver involvement in Gaucher disease : a practical review for the hepatologist and the gastroenterologist 2020 Cappellini M. D.Fargion S.Fracanzani A. L. + Article (author) -
Impact of natural neuromedin-B receptor variants on iron metabolism 2020 Rametta R.Dongiovanni P.Baselli G. A.Pelusi S.Meroni M.Fracanzani A. L.Fargion S.Valenti L. + Article (author) -
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes 2020 Lombardi R.Orsi E.Fargion S.Fracanzani A. L. + Article (author) -
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage 2020 Lombardi R.Pisano G.Dongiovanni P.Valenti L.Fargion S.Fracanzani A. L. + Article (author) -
High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation : preliminary results 2020 Pisano G.Oberti G.Borroni V.Lombardi R.Invernizzi F.Bertelli C.Porzio M.Dondossola D.Rossi G.Fargion S.Fracanzani A. L. + Article (author) -
Nutrients, genetic factors, and their interaction in non-alcoholic fatty liver disease and cardiovascular disease 2020 Lombardi R.Iuculano F.Pallini G.Fargion S.Fracanzani A. L. Article (author) -
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD 2020 Dongiovanni P.Meroni M.Longo M.Valenti L.Miele L.Fargion S.Fracanzani A. L. + Article (author) -
Evaluation of three “beyond Baveno VI” criteria to safely spare endoscopies in compensated advanced chronic liver disease 2019 Tosetti, GiuliaLa Mura, VincenzoD'Ambrosio, RobertaDegasperi, ElisabettaMezzina, NicolòViganò, MauroRumi, MariagraziaFracanzani, Anna LudovicaLombardi, RosaFargion, SilviaAghemo, AlessioLampertico, Pietro + Article (author) -
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 2019 Pelusi, SCespiati, ARametta, RBaselli, GDongiovanni, PFracanzani, A LBadiali, SFargion, SValenti, Luca + Article (author) -
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 2019 Pelusi S.Baselli G.Pietrelli A.Dongiovanni P.Donati B.Meroni M.Fracanzani A. L.Fargion S.Aghemo A.De Francesco R.Valenti L. V. C. + Article (author) -
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 2019 Mannucci P. M.Cesari M.Licata G.Violi F.Ardoino I.Pulixi E. A.Cappellini M. D.Maira D.Di Stefano V.Fabio G.Mancarella M.Damanti S.Clerici M.Lenti M. V.Pisati M.Romanelli G.Zucchelli A.Gallo P.Annoni G.Brucato A.Ghidoni S.Fabris F.Agosti P.Fargion S.Porzio M.Tiraboschi S.Peyvandi F.Rossio R.Monzani V.Savojardo V.Pallini G.Bianchi G. B.Del Vecchio S.Leonardi R.Gasparini F.Prolo S.Nava M. C.Baldassarre S.Rinaldi L.Famularo G.Morganti S.Artoni A.Montalto G.Quadri R.Tedeschi A.Harari S.Lopez S. + Article (author) -
Progressive splenomegaly and mild thrombocytosis in beta-thalassaemia trait and coexisting hereditary hemochromatosis: possible confounders for a subsequent hematological diagnosis 2019 Pelusi, SerenaIuculano, FedericaLombardi, RosaFrancione, PaoloGianelli, UmbertoFracanzani, Anna LudovicaFargion, Silvia Article (author) -
Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes : evidence in NAFLD patients and cell cultures 2019 Gomaraschi, MonicaFracanzani, Anna LudovicaDongiovanni, PaolaPavanello, ChiaraGiorgio, EleonoraDa Dalt, LorenzoNorata, Giuseppe DaniloCalabresi, LauraLombardi, RosaBranchi, AdrianaFargion, Silvia + Article (author) -